-
The Relationship Between IL-6 and IL-10 Expression Levels and the Prognosis in B-Cell Non-Hodgkin Lymphoma Patients Treated with R-CHOP
25 Oct 2025 13:48 GMT
… have: DLBCL, Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL), Chronic Lymphocytic … ’ treatment process. Besides, different lymphoma subtypes limit the generalizability of … . China Anti-cancer Association Lymphoma Committee. Clinical practice guideline …
-
<![CDATA[Understanding Your Stage 2 Lymphoma Diagnosis ]]>
25 Oct 2025 00:50 GMT
… on the specific type of lymphoma:
Hodgkin Lymphoma (HL): Generally has a … aggressive and many intermediate-risk lymphomas.
Hodgkin Lymphoma (HL): The standard regimen … .
Managing Side Effects of Lymphoma Treatment
Modern lymphoma treatments are often highly …
-
<![CDATA[Additional Resources Needed in the Community Setting to Manage CAR T in Patients With B-Cell Lymphoma ]]>
24 Oct 2025 15:01 GMT
Dr Friedman identifies communication challenges in community settings where care guidelines may not reach all team members involved in patient care. While Dana-Farber provides comprehensive written instructions via email, these may not be prominently …
-
<![CDATA[Considerations for Patients With B-Cell Lymphoma CAR T to Be Treated in the Community Setting ]]>
24 Oct 2025 15:01 GMT
Dr Friedman raises concerns about the “4 out of 5” patients who should receive CAR T but don't, attributing this to social determinants of health, geographic barriers, age-related factors, and other access challenges. He acknowledges the trend toward …
-
Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move
24 Oct 2025 13:26 GMT
… B-cell non-Hodgkin’s lymphoma, continuing what has been a …
-
<![CDATA[Two Doses of PCV20 in Lymphoma Survivors Elicits Greater Humoral Response]]>
24 Oct 2025 02:12 GMT
… to 1 in survivors of lymphoma at 1- and 3- … in survivors of B-cell lymphoma who received prior anti- … is Vaccination for Survivors of Lymphoma Important?
Anti-CD20 monoclonal antibodies … conjugate vaccine (PCV20) in lymphoma survivors at 3 months follow …
-
<![CDATA[Dr Wang on a Retrospective Study of CNS Bridging Radiotherapy Prior to CAR T in B-Cell Lymphoma]]>
24 Oct 2025 02:03 GMT
… #47;refractory B-cell lymphoma involving the central nervous … /refractory B-cell lymphomas.
The study, findings from … #47;refractory B-cell lymphoma involving the CNS who … enrolled patients had secondary CNS lymphoma. Specifically, disease histologies …
-
Spatial Analysis Finds Immune-Rich Pockets in Diffuse Large B-Cell Lymphoma Tumors with Clear Treatment Potential
23 Oct 2025 03:10 GMT
… within diffuse large B-cell lymphoma (DLBCL)
Immune-privileged DLBCLs contain … of diffuse large B-cell lymphoma (DLBCL), researchers from The University … Green, Ph.D, professor of Lymphoma/;Myeloma, and Linghua Wang …
-
<![CDATA[The Potential Role of Targeted Therapy for Secondary T-Cell Lymphoma After CAR T-Cell Therapy]]>
23 Oct 2025 02:50 GMT
… CAR-positive T-cell lymphomas—after CAR T-cell … patients with cutaneous T-cell lymphomas. However, it is rarely … hematopoiesis and T-cell lymphomas and may have contributed … driving T-cell transformation and lymphomagenesis,” study authors concluded. “We …
-
<![CDATA[FDA Grants Fast Track Designation to EO2463 for Follicular Lymphoma]]>
22 Oct 2025 19:17 GMT
… , or disease progression by Lymphoma Response to Immunomodulatory Therapy Criteria … relapsed or refractory follicular lymphoma or marginal zone lymphoma who previously received … fast track designation in follicular lymphoma for lead OncoMimics immunotherapy …
About
© 1995-2025